Immunomodulating effects of surgical intervention in tumors of the head and neck

Otolaryngology - Head and Neck Surgery

Volumn 123, Issue 1, 2000, Pages 132-139

  Dietz, Andreas ^a   Heimlich, Florian ^a   Daniel, Volker ^a   Polarz, Heinrich ^a   Weidauer, Hagen ^a   Maier, Heinz ^b  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b Military Hospital Ulm   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; CYTOKINE RECEPTOR; GAMMA INTERFERON; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 3; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 6 RECEPTOR; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ANESTHESIA; ARTICLE; CANCER RADIOTHERAPY; CANCER SURGERY; CELLULAR IMMUNITY; CLINICAL ARTICLE; CYTOKINE RELEASE; DOWN REGULATION; FEMALE; HEAD TUMOR; HUMAN; IMMUNE DEFICIENCY; IMMUNOMODULATION; INTENSIVE CARE; LARYNX CARCINOMA; LYMPHOCYTE ACTIVATION; LYMPHOCYTE COUNT; LYMPHOCYTE DEPLETION; MALE; MOUTH CARCINOMA; NECK TUMOR; OPERATION DURATION; PHARYNX CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; CD4-CD8 RATIO; CYTOKINES; FEMALE; HUMANS; IMMUNE TOLERANCE; LARYNGEAL NEOPLASMS; LYMPHOCYTE ACTIVATION; LYMPHOCYTE COUNT; MALE; MIDDLE AGED; MOUTH NEOPLASMS; NEOPLASM STAGING; PHARYNGEAL NEOPLASMS; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 0346048212     PISSN: 01945998     EISSN: None     Source Type: Journal    
DOI: 10.1067/mhn.2000.104669     Document Type: Article

References (22)

1. Wustrow TPU, Mahnke CG. Causes of immunosuppression in squamous cell carcinoma of the head and neck. Anticancer Res. 16:1996;2433-2468.
2. Faist E, Schinkel C, Zimmer S. Update on the mechanism of immune suppression of injury and immune modulation. World J Surg. 20:1996;454-459.
3. Friccione G, Bilfinger T, Jandorf L. Surgical anticipatory stress manifests itself in immunocyte desensitization: evidence for autoimmunoregulatory involvement. Int J Cardiol. 53:1996;65-73.
4. Ertel W, Faist E, Nestle C. Kinetics of interleukin-2 and interleukin-6 synthesis following major mechanical trauma. J Surg Res. 48:1990;622-628.
5. Faist E, Markewitz A, Fuchs D. Immunomodulatory therapy with thymopentin and indomethacin successful restoration of interleukin-2 synthesis in patients undergoing major surgery. Ann Surg. 214:1991;264-275.
6. Eskola J, Salo M, Viljanen MK. Impaired B lymphocyte function during open heart surgery. Br J Anaesth. 56:1984;333-338.
7. O'Mahoney JB, Palder SB, Wood JJ. Depression of cellular immunity after multiple trauma in the absence of sepsis. J Trauma. 24:1984;869-875.
8. Faist E, Mewes A, Baker CC. Prostaglandin E dependent suppression of interleukin-2 production in patients with major trauma. J Trauma. 27:1987;837-848.
9. Goodwin JS, Ceuppens J. Regulation of the immune response by prostaglandins. J Clin Immunol. 3:1983;295-315.
10. Wanner GA, Müller P, Ertel W. Differential effect of cyclooxygenase metabolites on proinflammatory cytokine release by Kupffer cells after liver ischemia and reperfusion. Am J Surg. 175:1998;146-151.
11. Daniel V, Schimpf K, Opelz G. Lymphocyte autoantibodies and alloantibodies in HIV-positive hemophilia patients. Clin Exp Immunol. 75:1989;178-183.
12. Ertel W, Friedel HP, Trentz O. Multiple organ dysfunction syndrome (MODS) following multiple trauma: rationale and concept of therapeutic approach. Eur J Pediatr Surg. 4:1994;243-248.
13. Ayala A, Meldrum DR, Perrin MM. The release of transforming growth factor-β following haemorrhage: its role as a mediator of host immunosuppression. Immunology. 79:1993;479-484.
14. Bristol LA, Ruscetti FW, Brody DT. IL-1α induces expression of active transforming growth factor-β in nonproliferating T-cells via a post-transcriptional mechanism. J Immunol. 145:1990;4108-4114.
15. Stephan RN, Kupper TS, Geha AS. Hemorrhage without tissue trauma produces immunosuppression and enhances susceptibility to sepsis. Arch Surg. 122:1987;62-68.
16. Heiss MM, Frauenberger P, Delanoff C. Modulation of immune response by blood transfusion - evidence for a differential effect of allergenic and autologous blood in colorectal cancer surgery. Shock. 8:1997;402-408.
17. Maetani S, Nishikawa T, Hirakawa A. Role of blood transfusion in organ system failure following major abdominal surgery. Arch Surg. 3:1986;275-281.
18. Spiers EM, Potts RC, Simpson JRM. Mechanisms by which barbiturates suppress lymphocyte responses to phytohaemagglutinin stimulation. Int J Immunopharmacol. 9:1987;505-512.
19. Kress HG, Eberlein T. Effect of anesthesia and operation on essential immune functions. Anaesthesiol Intensivmed Notfallmed Schmerzther. 27:1992;393-402.
20. Chesi R, Cazzola A, Bacci G. Effect of perioperative transfusions on survival in osteosarcoma treated by multimodal therapy. Cancer. 97:1989;225-230.
21. Spiers EM, MacConnachie A, Beck JS. Etomidate does not suppress PHA-induced growth of normal human lymphocytes. Lancet. 2:1983;511.
22. Levy EM, McIntosh T, Black PH. Elevation of circulating B-endorphin levels with concomitant depression of immune parameters after traumatic injury. J Trauma. 26:1986;246-249.